trial

Honest Open Proud for Psychotic and Bipolar Disorder in Norway

NCTId NCT06384755
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 40 (estimated)
Sponsored by Oslo University Hospital
Primary completion 2024-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
40 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2024-04-20
Primary completion
2024-12-31
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Honest Open Proud program

Sponsors

Oslo University HospitalLead Sponsor
University of OsloCollaborator

Investigators

1
Carmen Simonsen, PhDPrincipal Investigator

Sites

2 total
Oslo, NorwayOslo, Norway

Facts & assertions

4 sourced
Enrollment
40
Phase
NA
Primary Completion Date
2024-12-31
Status
RECRUITING
relationships
The graph out of here
drug
Honest Open Proud program
drug
lead_sponsor
Oslo University Hospital
company
collaborator
University of Oslo
company
indication
Bipolar Disorder
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
investigator
Carmen Simonsen, PhD
person